138 related articles for article (PubMed ID: 1466156)
1. Histology and immunocytochemistry of differentiated thyroid carcinomas do not predict radioiodine uptake: a clinicomorphological study of 62 recurrent or metastatic tumours.
Bätge B; Dralle H; Padberg B; von Herbay B; Schröder S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):521-6. PubMed ID: 1466156
[TBL] [Abstract][Full Text] [Related]
2. Comparison of histology and immunohistochemistry with thyroglobulin serum levels and radioiodine uptake in recurrences and metastases of differentiated thyroid carcinomas.
Dralle H; Schwarzrock R; Lang W; Böcker W; Ziegler H; Schröder S; Geerlings H
Acta Endocrinol (Copenh); 1985 Apr; 108(4):504-10. PubMed ID: 3887828
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases.
Stefăneanu L; Taşcă C
Acta Histochem; 1986; 78(1):7-18. PubMed ID: 2421518
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and Triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method.
Kawaoi A; Okano T; Nemoto N; Shiina Y; Shikata T
Am J Pathol; 1982 Jul; 108(1):39-49. PubMed ID: 7046455
[TBL] [Abstract][Full Text] [Related]
5. Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study.
Mizukami Y; Michigishi T; Nonomura A; Hashimoto T; Terahata S; Noguchi M; Hisada K; Matsubara F
Hum Pathol; 1990 Mar; 21(3):283-90. PubMed ID: 2312106
[TBL] [Abstract][Full Text] [Related]
6. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
7. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
8. Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases.
Druetta L; Bornet H; Sassolas G; Rousset B
Eur J Endocrinol; 1999 May; 140(5):457-67. PubMed ID: 10229914
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin immunostaining in follicular thyroid carcinoma: relationship to the degree of differentiation and cell type.
Harach HR; Franssila KO
Histopathology; 1988 Jul; 13(1):43-54. PubMed ID: 3061922
[TBL] [Abstract][Full Text] [Related]
10. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
11. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
12. Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?
Giammarile F; Hafdi Z; Bournaud C; Janier M; Houzard C; Desuzinges C; Itti R; Sassolas G; Borson-Chazot F
Eur J Endocrinol; 2003 Oct; 149(4):293-300. PubMed ID: 14514343
[TBL] [Abstract][Full Text] [Related]
13. Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma.
Lin JD; Kao PF; Weng HF; Lu WT; Huang MJ
Eur J Nucl Med; 1998 Jul; 25(7):695-700. PubMed ID: 9662590
[TBL] [Abstract][Full Text] [Related]
14. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
Golger A; Fridman TR; Eski S; Witterick IJ; Freeman JL; Walfish PG
J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormones in differentiated thyroid cancer.
Samuel AM; Mehta MN; Desai KB
Clin Nucl Med; 1994 Jan; 19(1):49-53. PubMed ID: 8137584
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
18. Incidentally detected liver metastasis of well-differentiated follicular carcinoma of the thyroid, mimicking ectopic thyroid.
Kondo T; Katoh R; Omata K; Oyama T; Yagawa A; Kawaoi A
Pathol Int; 2000 Jun; 50(6):509-13. PubMed ID: 10886730
[TBL] [Abstract][Full Text] [Related]
19. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
[TBL] [Abstract][Full Text] [Related]
20. Production of thyroxine (T4) and triiodothyronine (T3) in nontoxic thyroid tumors. An immunohistochemical study.
Kawaoi A; Okano T; Nemoto N; Shikata T
Virchows Arch A Pathol Anat Histol; 1981; 390(3):249-57. PubMed ID: 7025437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
